Exagen (XGN) PT Raised to $7 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Ross Osborn raised the price target on Exagen (NASDAQ: XGN) to $7.00 (from $5.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
